90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL

Clinical trial NCT00186589 · COMPLETED

Trial details

NCT number: NCT00186589
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Blood and Marrow Transplant (BMT)

Start date: 2004-05-01
Primary completion: 2007-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.